From Suspects to the Spitterati: A collision of power, profit, and privacy
By Jessica Cussins
| 06. 27. 2013
DNA is the ultimate big-data dream. It can shed light on our health, ancestry, and family members. It can be used to solve crimes and exonerate the innocent, investigate diseases and treatments, advance basic scientific knowledge, and reveal certain aspects of our histories and potential futures.
But as genetic data is collected and used in increasingly varied contexts, issues of privacy, rights, access, justice, and innovation are poised to collide – and to intersect our lives in both positive and negative ways. The questions raised by this coming collision won’t be answered immediately, but we need to start now to tease out their complexities.
Many suitors are lining up to exploit the explosion of genetic information.
- Local police agencies are creating their own databases – some call them “rogue” databases – and the Supreme Court recently determined that state and federal authorities can take DNA from people arrested (pre-conviction) for serious crimes.
- Companies are rushing to patent genetic findings, even when such claims are absurd (and now, at least partially, ruled unconstitutional by the Supreme Court).
- Marketing and advertising gurus...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...